If the FDA is looking for a streamlined approach to respond to the opioid crisis, it didn't come from a public meeting of the agency's Opioid Policy Steering Committee.
Trending:
FDA and opioids: too much regulation or not enough?
If the FDA is looking for a streamlined approach to respond to the opioid crisis, it didn't come from a public meeting of the agency's Opioid Policy Steering Committee.